Encore Capital Group - ECPG Stock Forecast, Price & News

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Encore Capital Group in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ECPG shares.
View ECPG analyst ratings or view top-rated stocks.

2 Wall Street analysts have issued twelve-month price objectives for Encore Capital Group's stock. Their ECPG share price forecasts range from $71.00 to $87.00. On average, they expect the company's share price to reach $79.33 in the next twelve months. This suggests a possible upside of 42.3% from the stock's current price.
View analysts price targets for ECPG or view top-rated stocks among Wall Street analysts.

Encore Capital Group's stock was trading at $62.11 on January 1st, 2022. Since then, ECPG shares have decreased by 10.2% and is now trading at $55.77.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 2nd 2022.
View our ECPG earnings forecast.

Encore Capital Group, Inc. (NASDAQ:ECPG) issued its earnings results on Wednesday, November, 3rd. The asset manager reported $2.66 EPS for the quarter, topping analysts' consensus estimates of $2.12 by $0.54. The asset manager had revenue of $412.62 million for the quarter, compared to analysts' expectations of $372.31 million. Encore Capital Group had a net margin of 24.34% and a trailing twelve-month return on equity of 31.28%. During the same period in the prior year, the business posted $2.31 EPS.

122 employees have rated Encore Capital Group Chief Executive Officer Ashish Masih on Glassdoor.com. Ashish Masih has an approval rating of 79% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Encore Capital Group investors own include BioTelemetry (BEAT), JPMorgan Chase & Co. (JPM), PayPal (PYPL), SEA (SE), AbbVie (ABBV), Novavax (NVAX), Pfizer (PFE), Invesco QQQ Trust (QQQ), AT&T (T) and Advanced Micro Devices (AMD).

Encore Capital Group trades on the NASDAQ under the ticker symbol "ECPG."

Encore Capital Group's stock is owned by a variety of institutional and retail investors. Top institutional investors include FMR LLC (6.68%), BloombergSen Inc. (4.95%), Turtle Creek Asset Management Inc. (4.65%), Principal Financial Group Inc. (3.77%), Bank of Montreal Can (2.06%) and JPMorgan Chase & Co. (1.96%). Insiders that own company stock include Gregory L Call, Laura Olle, Ryan B Bell and Wendy Hannam.
View institutional ownership trends.

Shares of ECPG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ECPG stock can currently be purchased for approximately $55.77.

Encore Capital Group (NASDAQ:ECPG) has a market capitalization of $1.33 billion and generates $1.61 billion in revenue each year. The asset manager earns $350.78 million in net income (profit) each year or $13.88 on an earnings per share basis.

The company employs 6,604 workers across the globe.

Encore Capital Group was founded in 1953.

Encore Capital Group's mailing address is 350 CAMINO DE LA REINA SUITE 100, SAN DIEGO CA, 92108. The official website for the company is www.encorecapital.com. The asset manager can be reached via phone at (877) 445-4581, via email at bruce.thomas@encorecapital.com, or via fax at 858-309-6978.